Harris Rotman

Harris Rotman is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Vice President and Head of Global Regulatory Affairs at Madrigal Pharmaceuticals, Rotman has held senior positions at various organizations, including Centessa Pharmaceuticals and SwanBio Therapeutics. Prior roles include Vice President at Endo Pharmaceuticals and Indivior, where responsibilities encompassed overseeing global regulatory affairs. Harris Rotman earned a Ph.D. in Microbiology and Molecular Virology from Jefferson Health and a B.S. in Biological Sciences from Rutgers University.